NCT00532766

Evaluating Pharmacokinetics and Pharmacodynamics of Jusline

Bioequivalence of Jusline Following Subcutaneous Administration in Healthy Subjects

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: King Saud University · Academic / Other
• Sex: Male
• Age: 18 Years – 35 Years
• Healthy volunteers: Accepted

Summary

To evaluate the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline) after subcutaneous administration, and to compare this profile with Humulin insulin.

Detailed description

To study the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline) after subcutaneous administration in the abdominal, and to compare this profile with Humulin insulin for three different preparations (Regular, NPH, and Premixed Regular/NPH (30/70)).

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Jusline

Timeline

• Start date: 2006-11-01
• Completion: 2007-02-01
• First posted: 2007-09-20
• Last updated: 2007-09-26

Locations

1 site across 1 country: Saudi Arabia